187 related articles for article (PubMed ID: 3083214)
41. The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
Tesser JR; Rothberger H; Agudelo C
J Rheumatol; 1983 Apr; 10(2):227-34. PubMed ID: 6345769
[TBL] [Abstract][Full Text] [Related]
42. [Autoantibodies against histones and actin determined by western blotting in patients with rheumatic diseases].
Raska I; Petrasovicová V; Jarník M; Cebecauer L; Lukacovicová L; Lejnar J; Viklický V; Mácha J; Jíra M; Trnavský K
Cas Lek Cesk; 1990 Nov; 129(47):1495-500. PubMed ID: 2257596
[TBL] [Abstract][Full Text] [Related]
43. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity.
Molden DP; Nakamura RM; Tan EM
Am J Clin Pathol; 1984 Jul; 82(1):57-66. PubMed ID: 6377871
[TBL] [Abstract][Full Text] [Related]
44. Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.
Pisetsky DS
Scand J Immunol; 2012 Sep; 76(3):223-8. PubMed ID: 22670594
[TBL] [Abstract][Full Text] [Related]
45. Anticentromere antibodies: clinical and biological significance.
Fritzler MJ; Ayer LM
J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
[No Abstract] [Full Text] [Related]
46. Nuclear matrix antibodies in rheumatic diseases.
Kurki P; Virtanen I; Lehto VP; Helve T
J Rheumatol; 1985 Apr; 12(2):253-6. PubMed ID: 3897532
[TBL] [Abstract][Full Text] [Related]
47. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
48. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
49. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma.
Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM
Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706
[TBL] [Abstract][Full Text] [Related]
50. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists.
Kavanaugh A; Tomar R; Reveille J; Solomon DH; Homburger HA
Arch Pathol Lab Med; 2000 Jan; 124(1):71-81. PubMed ID: 10629135
[TBL] [Abstract][Full Text] [Related]
51. [A comparative study of antinuclear antibody measurement using different cells as nuclear substrates].
Yang JS; Hsieh RP; Shen MC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):299-310. PubMed ID: 1818799
[TBL] [Abstract][Full Text] [Related]
52. Cytoplasmic staining, ANA negative status, and ENA testing in rheumatic diseases.
Lems WF; van Schaardenburg D; van de Stadt RJ
Ann Rheum Dis; 1995 Sep; 54(9):779. PubMed ID: 7495352
[No Abstract] [Full Text] [Related]
53. Significance of anti-nuclear matrix antibodies in patients with in vivo speckled antinuclear antibody staining.
Deng JS; Benedict L; Deng DH; Oddis CV; Fratto J
Arthritis Rheum; 1996 Aug; 39(8):1300-7. PubMed ID: 8702437
[TBL] [Abstract][Full Text] [Related]
54. Recent progress in the study of autoantibodies to nuclear antigens.
Nakamura RM; Tan EM
Hum Pathol; 1978 Jan; 9(1):85-91. PubMed ID: 344192
[TBL] [Abstract][Full Text] [Related]
55. [Diagnosis of rheumatologic diseases. Significance of autoantibodies against nuclear antigens].
Poralla T; Mayet W; Hermann E; Manns M; Meyer zum Büschenfelde KH
Fortschr Med; 1988 Dec; 106(36):726-9. PubMed ID: 3069672
[No Abstract] [Full Text] [Related]
56. Absence of autoantibodies in primary fibromyalgia.
Bengtsson A; Ernerudh J; Vrethem M; Skogh T
J Rheumatol; 1990 Dec; 17(12):1682-3. PubMed ID: 2084244
[TBL] [Abstract][Full Text] [Related]
57. [Autoimmune reactions in rheumatic diseases].
Maerker-Alzer G
Internist (Berl); 1990 Jan; 31(1):19-25. PubMed ID: 2137813
[No Abstract] [Full Text] [Related]
58. The identification of autoantigens, autoantibodies and their idiotypes.
Walport M
Br J Rheumatol; 1987 Jun; 26(3):161-3. PubMed ID: 3107648
[No Abstract] [Full Text] [Related]
59. Emerging technologies in autoantibody testing for rheumatic diseases.
Olsen NJ; Choi MY; Fritzler MJ
Arthritis Res Ther; 2017 Jul; 19(1):172. PubMed ID: 28738887
[TBL] [Abstract][Full Text] [Related]
60. [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].
Helmke K; Scheuermann R; Boeder T; Oppermann M; Teuber J; Federlin K
Klin Wochenschr; 1981 Mar; 59(6):287-96. PubMed ID: 7015004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
